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Abstract
Intra-abdominal hypertension (IAH) is an important contributor to early organ dysfunction in trauma and sepsis. How-
ever, relatively little is known about the impact of intra-abdominal pressure (IAP) in general internal medicine, pregnant 
patients, and those with obesity or burns. The aim of this paper is to review the pathophysiologic implications and 
treatment options for IAH in these specific situations. A MEDLINE and PubMed search was performed and the result-
ing body-of-evidence included in the current review on the basis of relevance and scientific merit. There is increasing 
awareness of the role of IAH in different clinical situations. Specifically, IAH will develop in most (if not all) severely 
burned patients, and may contribute to early mortality. One should avoid over-resuscitation of these patients with 
large volumes of fluids, especially crystalloids. Acute elevations in IAP have similar effects in obese patients compared 
to non-obese patients, but the threshold IAP associated with organ dysfunction may be higher. Chronic elevations in 
IAP may, in part, be responsible for the pathogenesis of obesity-related co-morbid conditions such as hypertension, 
pseudotumor cerebri, pulmonary dysfunction, gastroesophageal reflux disease, and abdominal wall hernias. At the 
bedside, measuring IAP and considering IAH in all critical maternal conditions is essential, especially in preeclamp-
sia/eclampsia where some have hypothesized that IAH may have an additional role. IAH in pregnancy must take 
into account the precautions for aorto-caval compression and has been associated with ovarian hyperstimulation 
syndrome. Recently, IAP has been associated with the cardiorenal dilemma and hepatorenal syndrome, and this has 
led to the recognition of the polycompartment syndrome. In conclusion, IAH and ACS have been associated with 
several patient populations beyond the classical ICU, surgical, and trauma patients. In all at risk conditions the focus 
should be on the early recognition of IAH and prevention of ACS. Patients at risk for IAH should be identified early 
through measurements of IAP. Appropriate actions should be taken when IAP increases above 15 mm Hg, especially if 
pressures reach above 20 mm Hg with new onset organ failure. Although non-operative measures come first, surgical 
decompression must not be delayed if these fail. Percutaneous drainage of ascites is a simple and potentially effec-
tive tool to reduce IAP if organ dysfunction develops, especially in burn patients. Escharotomy may also dramatically 
reduce IAP in the case of abdominal burns. 
Key words: abdominal hypertension, abdominal compartment syndrome, specific conditions, pregnancy, obstetrics, 
gynecology, obesity, internal medicine, burns
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Intra-abdominal hypertension (IAH) is an important con-
tributor to early organ dysfunction in emergency general 
surgery, trauma, and sepsis patients. However, relatively 
little is known about the impact of intra-abdominal pressure 
(IAP) disturbances in general internal medicine and preg-
nant patients and those with obesity and burns. Although 
inciting pathologies are innumerable, the human patho-
physiologic responses to inflammation and injury are similar, 
and thus the paucity of knowledge concerning IAH/ACS in 
other populations likely represents a lack of awareness on 
the part of caregivers and researchers. The aim of this paper 
is to review the pathophysiological implications, diagnosis, 
and treatment options for IAH and abdominal compartment 
syndrome (ACS) in the above-mentioned specific situations.
METHODS
A MEDLINE and PubMed search was performed using 
the search terms (“abdominal compartment syndrome” or 
“abdominal hypertension” or “abdominal pressure”) and 
(“pregnancy” or “obstetrics” or “burns” or “obesity” or “heart 
failure” or “renal failure” or “endoscopy” or “ovarian hyper-
stimulation syndrome” or “eclampsia” or “polycompartment 
syndrome” or “cardiorenal syndrome” or “peritoneal dialy-
sis”). The identified abstracts were screened and selected 
on the basis of relevance, methodology, and scientific merit. 
Full text articles of the selected abstracts were used to sup-
plement the authors’ expert opinion and experience. The 
bibliographies of the selected papers were also reviewed 
for other relevant citations. The resulting references were 
included in the current review that focuses on IAH in burns, 
obesity, pregnancy, and general internal medicine. Each 
topic will be discussed separately, hereafter, related to 
practical clinical questions on definitions, epidemiology, 
pathophysiology, diagnosis, and prevention and treatment, 
and concluding with some key messages for the reader. This 
“extended” review may also be supplemented by a book 
chapter on the same topic in the Core Critical Care Series [1].
INTRA-ABDOMINAL HYPERTENSION  
IN BURN PATIENTS
PATHOPHYSIOLOGY AND EPIDEMIOLOGY  
OF IAH IN BURNS PATIENTS
Severely burned patients usually develop IAH/ACS 
within 48 hours after injury [2]. The generalized increase in 
capillary permeability that occurs in severe burn patients 
contributes to extensive edema formation and intra-peri-
toneal accumulation of “third-space” fluid [3]. Bowel edema 
and fluid translocation is further worsened by venous hyper-
tension caused by elevated IAP [4]. This increasing volume 
in the abdominal cavity, however, is reduced after capillary 
permeability improves. Therefore, secondary IAH in burn 
patients generally occurs within 48 hours after injury, during 
the initial resuscitation period, while ACS usually occurs after 
the acute phase, during subsequent septic episodes [5, 6]. 
Figure 1 shows the relationship between the resuscitation 
fluid volume within 24 hours post burn, percentage total 
body surface area (%TBSA), and complicating ACS.
The exact incidence of IAH and ACS among patients 
with burns is unknown, largely because it depends on the 
severity of burn injury, the method and frequency of IAP 
measurement, the exact definition used to define IAH, and 
the duration of IAP monitoring [7, 8]. A recent systematic 
Figure 1. Resuscitation fluid volume (within first 24 hours) and % TBSA (total burned surface area) in individual burn cases. Solid bars indicate 
patients with abdominal compartment syndrome. Adapted from Oda et al. [6]. All patients with ACS had received more than 300 mL kg 24h-1 and 
had more than 50% TBSA
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review showed that the prevalence of ACS and IAH in se-
verely burned patients is 4.1−16.6% and 64.7−74.5%, respec-
tively [9]. The mean mortality rate for ACS in burn patients 
is 74.8%. The risk of ACS is higher in burned patients with 
a higher percentage of TBSA burned; however, patients with 
a lower burned TBSA may develop IAH/ACS as well [6]. ACS 
typically occurs when resuscitation volumes are greater 
than 275 mL kg-1during the first 24 hours or TBSA burned 
is larger than 60% [6].
The effects of IAH/ACS in patients with severe burns are 
multifactorial. Raised IAP can lead to organ dysfunction and 
can affect all organ systems. The use of excessive fluid resusci-
tation in combination with increased capillary permeability as 
a result of the systemic inflammatory response to burn injury 
makes these patients particularly vulnerable to the develop-
ment of IAH and ACS and cardiovascular, respiratory, and renal 
system dysfunction [5]. In severe burn patients, the kidneys 
are especially vulnerable to elevated IAP-related injury [10]. 
Markers for IAP-related organ damage might be superior to 
IAP measurement itself [9]. Thus, clinicians must accurately 
monitor patient fluid balance in the resuscitation period. 
Since an elevated IAP affects renal blood flow, urinary output 
is an unreliable index of the preload and intravascular volume 
resulting in the loss of an important physiologic parameter. 
Moreover, ACS as well as abdominal decompression for ACS 
increases susceptibility to multiple organ dysfunction syn-
drome (MODS) for severe burn patients and may also induce 
acute lung injury. The mortality rate of patients developing 
ACS is 50−80%, even when treated. 
PREVENTION AND DIAGNOSIS OF IAH  
AND ACS IN BURN PATIENTS
Secondary IAH in burn patients generally seems to oc-
cur within 48 hours after injury, during the initial resuscita-
tion period. After this, when patients reach the ‘polyuric or 
diuretic phase’ (i.e., flow phase), the IAH/ACS risk decreas-
es. However, if patients develop sepsis, the risk for IAH/ACS 
increases again and those not progressing spontaneously 
to the flow phase may need intervention [11]. Burn patients 
are also at risk of tertiary or recurrent ACS any time they 
require aggressive resuscitation as, for instance, after any 
overly aggressive burn excision [3, 4].
IAH/ACS should be suspected in all patients with se-
vere burns. IAP measurement should therefore be per-
formed every 2 to 4 hours throughout the resuscitation 
period in burn patients with more than 20% TBSA. IAH 
exists when IAP exceeds 12 mm Hg and can result in early 
organ damage. Significant concern exists when the IAP 
exceeds 20 mm Hg, especially with new organ dysfunction 
as this defines the ACS, which is associated with a high 
mortality rate. One should pay attention to the fact that 
IAH/ACS might occur in patients without circumferential 
3rd degree burns of their trunk. Burn patients with smoke 
inhalation may also be at risk of fluid sequestration [12]. In 
such patients, measurement of extravascular lung water 
(EVLW) may be helpful [13, 14]. Figure 2 shows a case in 
which although the elasticity of the abdominal wall was 
not impaired, a tense abdomen was observed with IAP el-
evated to 60 cm H2O. Recognizing IAH before ACS develops 
is very important as this may allow one to initiate medical 
management options.
Key to the prevention of ACS is the early recognition and 
treatment of IAH. Many burn physicians lack awareness of 
the deleterious effects of raised IAP and do not regularly 
measure it [15]. As burn patients are at high risk of develop-
ing IAH and ACS early in their ICU stay, routine measurement 
of IAP is warranted. Judicious use of fluids and avoidance of 
fluid over-resuscitation is the key element in the prevention 
of secondary ACS [16]. Percutaneous drainage of abdominal 
fluid collection may reduce IAP, particularly in the burn 
patient [17, 18]. Moreover, the choice of resuscitation fluid 
among critically ill patients with burns may have a clinical 
importance. Randomized studies have shown that hyper-
tonic lactated saline (HLS) or plasma-based resuscitation 
requires less fluid and is associated with a lower risk of IAH 
and ACS [16]. Indeed, the use of plasma and hypertonic 
lactated resuscitation may prevent IAH or ACS. Despite the 
fact that colloids decrease resuscitation volume needs, no 
benefit in preventing IAH has been proven [9]. In order 
to assess correctly the fluid status of the burned patient, 
transpulmonary thermodilution monitoring and measure-
ment of volumetric indices like global end-diastolic volume 
(GEDV) and EVLW may be warranted in combination with 
functional hemodynamics [13, 14, 19−21]. It must be stated, 
however, that avoidance of burn shock and post-burn renal 
Figure 2. A severely burned (87% TBSA, 2nd degree) male, 20 hours 
post burn. Although elasticity of the abdominal wall was not 
impaired, a tense abdomen was observed, and the IAP elevated  
to 44 mm Hg
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failure was a major advance of the 20th century. Moreover, as 
much as one does not want to induce IAH/ACS, physicians taking 
care of burn patients must remember that they still need to resus-
citate severe burns. At present, however, how to do this remains 
an art rather than a science. Indeed, the fact is that over recent 
decades more fluids are being given to burn patients has led to 
the introduction of the concept of “fluid creep”, a phenomenon 
which may also be attributed to “opioid creep”.
Urinary output is often cited as an easy-to-use resuscita-
tion target in burn resuscitation. Although this may be true 
for some patients, when IAH and ACS develop, oliguria may 
no longer be related to fluid depletion, and increasing resus-
citation volumes may further worsen the problem of IAH [22]. 
MANAGEMENT OF IAH AND ACS  
IN BURN PATIENTS
Non-operative and percutaneous interventions may 
be applied before surgical decompression is considered. 
Nasogastric decompression, the use of neuromuscular 
blocking agents, and the removal of excess fluid by ultra-
sound-guided percutaneous drainage, or by a combination 
of continuous veno-venous hemofiltration (CVVH) with ul-
trafiltration and/or diuretics, are simple and possibly effec-
tive tools to reduce IAP [23]. An escharotomy of the trunk to 
improve abdominal wall compliance should be performed 
early, especially in the presence of 3rd degree burns [24, 25]. 
Although a midline laparotomy may make wound manage-
ment more difficult in abdominal burn patients, it remains 
very effective in reducing IAP.
Regardless of surgical decompression, it is important 
to continue to measure IAP postoperatively in order to 
recognize recurrent IAH and/or ACS. The open abdomen 
after a laparotomy requires a temporary abdominal closure 
technique. The presence of abdominal burns may pose spe-
cific challenges to the management of the open abdomen 
with regard to infectious complications. The presence of 
significant protein loss via an open abdomen needs to be 
considered [26]. Early enteral and/or parenteral nutrition is 
of the utmost importance in these hypercatabolic patients, 
although recent literature results may advocate the opposite 
in ICU patients [27]. However, strong emphasis needs to be 
placed on the tremendous morbidity and high mortality of 
an open abdomen in patients with burns. In addition, early 
use of percutaneous u/s guided drainage of peritoneal fluid 
can help prevent the development of IAH.
INTRA-ABDOMINAL HYPERTENSION  
AND OBESITY
EPIDEMIOLOGY OF INTRA-ABDOMINAL 
HYPERTENSION IN OBESITY
Obesity has reached epidemic proportions in the United 
States, as 30% of American adults are obese, defined as 
a body mass index (BMI) of 30−34 kg m-2 (with BMI cal-
culated as weight divided by height2). Morbid obesity is 
defined by a BMI of 35 kg m-2 or greater. A similar trend 
of increasing BMI has been observed in many countries 
around the world. An elevated waist circumference defines 
central obesity. The metabolic syndrome is characterized 
by three or more of the following: central obesity, elevated 
triglyceride concentrations, lower high-density lipoprotein 
cholesterol levels, elevated blood pressure, and high fasting 
glucose concentrations. Some have introduced the term 
“syndrome X” [28].
Central obesity (metabolic syndrome) with an increased 
waist circumference and sagittal abdominal diameter has 
been shown to be associated with an increase in IAP [28]. 
Obesity has repeatedly been found to be associated with 
IAH [29−31]. Lambert et al. found the mean IAP in obese 
subjects with a mean BMI of 55 ± 2 kg m-2 to be 8.8 ± 0.5 mm 
Hg, compared to the control group of lean females with 
a mean IAP of 0 ± 0.9 mm Hg [32]. Varela et al. found that, 
among 62 morbidly obese patients with a mean BMI of 
49 ± 10 kg m-2, 77% had an IAP of 7−14 mm Hg [33]. Such 
data illustrates the direct relationship between obesity and 
IAP. While the exact pathogenesis of elevated IAP among 
patients with obesity is currently not known, Lambert et 
al. hypothesize that this association may be due to a direct 
mass effect of intra-abdominal adipose tissue [32]. Recent 
studies have found that obesity leads to chronic elevation 
of IAP and that IAP is positively correlated with BMI [29]. In 
many patients IAP is 12 mm Hg or higher, putting them at 
risk of acute organ dysfunction. The “normal” values of IAP 
in the obese patients should therefore be considered be-
tween 7 and 14 mm Hg [34, 35]. A possible explanation for 
higher pressures in the obese is that there could be a direct 
effect from the intra-abdominal adipose tissue itself on the 
measurement of IAP. The relation of chronically elevated IAP 
with chronic organ dysfunction is attracting increasing at-
tention. This includes evidence that IAP elevation correlates 
with diminished pulmonary function and with systemic 
hypertension [36−38]. 
As baseline IAP is higher in morbidly obese patients, 
the influence of IAH and its possible dynamics of inducing 
organ dysfunction should certainly be considered. Although 
there are a number of chronic diseases possibly related to 
elevated IAP, higher than usual IAP levels may be required 
in morbidly obese patients before organ dysfunction devel-
ops. However, the physiologic reserve may also be lower in 
obese patients.
PATHOPHYSIOLOGY OF IAH IN OBESE PATIENTS
An increase in IAP can be either acute, as in ACS, or 
chronic, as with the development of morbid obesity or pos-
sibly pregnancy. Acutely elevated IAP has deleterious car-
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diovascular, renal, pulmonary, and splanchnic consequences 
and may require emergent abdominal decompression. In 
contrast, the chronic elevation of IAP, seen in morbid obesity, 
has been thought to contribute to other disease processes 
including hypertension, proteinuria, pseudotumor cerebri 
(PTC), pulmonary complications, gastro-esophageal reflux 
disease (GERD), urinary stress incontinence, venous stasis 
and abdominal wall hernias. However, the evidence in sup-
port or against these associations is limited.
An acute increase in IAP may produce an increase in 
central venous pressure and systemic vascular resistance, 
and a decrease in venous return, cardiac output, visceral 
blood flow, and renal blood flow [30, 39]. Thus, in the set-
ting of chronic IAP and morbid obesity, recent studies have 
suggested that obesity-induced IAH contributes to systemic 
arterial hypertension and many other serious conditions 
[29, 32, 33, 40, 41]. In contrast, a normal IAP appears to offer 
a protective effect against systemic hypertension. However 
the pathogenesis is currently unknown and other studies 
have not demonstrated this correlation.
Morbidly obese individuals have significantly higher IAP 
and a higher prevalence of PTC [39]. The relationship be-
tween abnormally high IAP and the development of PTC has 
been examined in animal models and clinical cases showing 
that acutely increasing IAP to 25 mm Hg above baseline 
causes a significant increase in intracranial pressure [39, 42, 
43]. PTC may result from increased pleural and intrathoracic 
pressures found in obese patients, which obstructs cerebral 
venous outflow via the jugular system. 
Morbidly obese individuals are at a higher risk of experi-
encing pulmonary complications. It has been demonstrated 
that both forced expiratory volume and forced vital capacity 
are inversely correlated to IAP, thereby suggesting that an el-
evated IAP may result in pulmonary restrictive disorders.
Gastro-esophageal reflux disease (GERD) is prevalent 
among the morbidly obese. In the setting of obesity-related 
IAH, the resistance gradient between the stomach and the 
gastro-esophageal junction changes: gastro-esophageal 
junction resistance is higher in obese subjects, compared to 
the lean control. However, neither Lambert nor Varela found 
GERD to be associated with elevated IAP [32, 33]. In fact, 
although counter-intuitive, Lambert et al. found GERD to be 
associated with a lower mean IAP in morbidly obese patients. 
MANAGEMENT OF IAH IN OBESE PATIENTS
Management of IAH is similar in obese patients and 
should correspond to the established guidelines for man-
agement of IAH/ACS [44]. However, this management is 
more challenging, and may be associated with higher 
complication rates. Although percutaneous drainage of 
intra-abdominal fluid collections may be more difficult, and 
open abdomen management in morbidly obese patients 
may pose more practical problems, in essence, the strategies 
are no different from non-obese patients. 
Chronic IAH has been postulated to cause incisional 
hernias in obesity. Studies on this topic however report no 
correlation between IAP and the presence of an incisional 
hernia [30]. However, most of these studies are too small to 
statistically analyze.
INTRA-ABDOMINAL HYPERTENSION  
DURING PREGNANCY
PATHOPHYSIOLOGY OF IAH DURING PREGNANCY
In the second and the third trimester of pregnancy, the 
uterus occupies a major part of the abdominal cavity, and 
in the supine position breathlessness and decreased blood 
pressure (“supine hypotension syndrome”) are often seen 
[45, 46]. These symptoms are due to restriction of diaphrag-
matic motion and compression of the inferior vena cava. 
IAP is usually only slightly elevated, except in some rare 
conditions like ovarian hyperstimulation syndrome (OHSS) 
[47]. Furthermore, the symptoms are alleviated in the lateral, 
sitting, or standing positions. Due to hormonal influences 
during pregnancy the abdominal wall is slowly stretched, 
increasing its compliance, which reduces the potential for 
an increase in IAP caused by the expanding uterus. As a re-
sult, end-organ dysfunction as seen in critically ill patients 
with acute primary or secondary IAH is rare because the 
body has time to adapt to the slowly increasing IAP levels 
during the pregnancy. However, if IAP increases acutely due 
to other reasons (e.g., haemorrhage or pneumoperitoneum 
during laparoscopy), perfusion of the uterus and the foetus 
may be severely compromised [48]. 
The expansion of intra-abdominal contents in the form 
of fluid or tissue is the fundamental cause of increasing IAP 
leading to the pathophysiology of IAH and ACS. Pregnancy, 
with a growing fetus and the increases in intra-abdominal 
fluid and tissue, could be considered a perfect storm for 
the development of IAH/ACS. In fact, several studies have 
demonstrated significant increases in IAP, particularly during 
the third trimester of pregnancy [46, 49−52]. However, IAP 
levels that would be expected to cause end-organ com-
promise in most patients seem to be well tolerated in the 
gravid female. As mentioned above, the gradual onset of 
IAP with pregnancy allows for adaptation to pressures that 
might otherwise cause harm [45]. One mechanism for this 
adaptation is thought to be the development of collateral 
blood flow from the lower extremities and abdomen [53]. It 
has been generally accepted that these adaptations nullify 
the risk for the development IAH/ACS in pregnancy. How-
ever with an ever-increasing understanding of the subtle 
and significant physiologic effects of elevated IAP we are 
beginning to recognize the possibility that IAH/ACS may be 
a direct cause or contributing factor to several common dis-
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ease processes in pregnancy that can affect both the mother 
and the fetus. These include pre-eclampsia; eclampsia; he-
molysis, elevated liver enzymes, and low platelet counts 
(HELLP) syndrome; fetal hypertension and fetal bladder; and 
urinary tract dysfunction [51, 54−62]. Despite adaptation for 
elevated IAP in pregnancy, risk factors for IAH/ACS do still 
exist but may be difficult to quantify given that pregnancy 
introduces a unique physiology, which therefore introduces 
unique risk factors and IAH related disease processes. These 
conditions may thus require unique monitoring endpoints. It 
is still unclear whether the incidence of preeclampsia and 
IAH in first pregnancies is different from that in multiparous 
women.
Despite the limited understanding of IAH in maternal 
care, even less is known regarding its effects on the fetus 
[45]. Several animal studies have confirmed that the mam-
malian fetus in utero is subject to transmitted IAP [57, 58, 63]. 
IAH was found to decrease uterine blood flow and induced 
a resultant compensatory fetal hypertension [64] similar to 
that seen during laparoscopy even with inert gasses rather 
than CO2. In a gravid rabbit model, Karnak et al. found that 
intra-amniotic pressure (IAMNP) was linearly related to IAP 
as defined by IAMNP = IAP × 0.8 + 2.0. The IAP and IAMNP 
were measured through catheters inserted respectively 
into both the intraperitoneal and intraamniotic cavities at 
20 days gestation [58]. Given the increasing tolerance for 
laparoscopic surgery in gravid females, further research in 
this area is of critical importance. 
Adapting to a growing fetus requires significant physi-
ologic changes in the female body. These include normally 
induced relaxation of ligamentous tissue to accommodate 
the growing fetus; overall increase in cardiac output by 50% 
and an eight to ten fold increase in uterine blood flow [65, 
66]. In addition, an adaptation that may protect against the 
effects of increased IAP occurs through the development 
of collateral blood flow that develops in anatomic regions 
less impacted by increased IAP including the vertebral and 
epidural vascular system [53]. However, variation in the 
development of these collateral vessels increases the risk 
of supine hypotensive syndrome caused by compression 
of the inferior vena cava and may also increase risk for the 
effects of IAH/ACS. 
INDICATIONS FOR IAP MEASUREMENT  
DURING PREGNANCY
Although there is a dearth of literature on the effects 
of increased IAP in pregnancy, it is intuitive that pregnant 
patients are uniquely at risk of IAH/ACS due to the develop-
ment of both acute and chronic IAP elevation [45]. While, 
there is no evidence to suggest that monitoring IAP is 
necessary in an uncomplicated pregnancy, as with other 
chronically adaptive IAP processes like obesity, chronic liver 
failure with ascites, and tumors, IAP monitoring and clinical 
decision-making should be based on trended pressures and 
clinical presentation rather than utilizing standard pressure 
measurements [35]. Patients with significant increases in 
IAP and concomitant organ failure should be considered 
for medical and/or surgical IAH/ACS management. To not 
consider IAH/ACS in such critical situations could be life 
threatening for both mother and fetus.
The clinician must be aware that body position affects 
IAP. Chun et al. found that IAP measurements were sig-
nificantly higher in the fully supine position compared with 
a leftward position of 10° [46]. The authors hypothesized that 
the weight of the gravid uterus might have direct impact on 
the bladder, thereby falsely elevating the IAP measurement 
when fully supine. 
Questions arise as to the validity of IAP measurements 
per WSACS guidelines in a pregnant patient after the 2nd 
trimester. Current guidelines describe IAP measurement 
in the fully supine position at end-expiration [23, 67]. Such 
a maneuver in pregnancy, however, could be detrimental, 
and we cannot recommend it [45]. 
RELATION OF IAH WITH PREECLAMPSIA  
AND ECLAMPSIA
Preeclampsia, part of a spectrum of hypertensive dis-
orders of pregnancy, is defined as the development of ar-
terial hypertension and proteinuria after 20 weeks gesta-
tion [45, 68], and is associated with significant maternal 
morbidity and death [68, 69]. Two dramatic case reports 
have described overt ACS as a complication of preeclamp-
sia/eclampsia/HELLP (H — hemolysis, EL — elevated liver 
enzymes, LP — low platelet count) syndromes requiring 
urgent life-saving interventions [54, 55]. The diagnosis of 
peripartum ACS in these cases was challenging not only due 
to the lack of well-established normative pregnant values of 
IAP, but also because of the overlap of signs and symptoms 
between ACS and severe preeclampsia such as oliguria, and 
nonspecific abdominal pain [35, 54]. Sugerman has recently 
hypothesized that IAH plays a central role in initiating the 
multi-system cascade of diminished perfusion and inflam-
mation associated with the various clinical manifestations 
of preeclampsia [51]. 
Toxemia of pregnancy occurs in 5 to 14% of pregnancies 
and represents a spectrum of obstetrical disease beginning 
with preeclampsia and including eclampsia and HELLP syn-
drome [70−72]. Numerous theories have attempted to ex-
plain this disease process without a clear unifying theory. It 
has been suggested that increased IAP may be an important 
trigger to this type of physiology through an IAP-induced 
reduction of renal blood flow which, in turn, activates the 
renin-angiotensin axis resulting in systemic hypertension 
and decreased placental blood flow. A relationship is further 
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suggested in that most toxemia occurs in the third trimester 
when IAP is most elevated. In addition, we speculate that the 
cure for toxemia, namely fetal delivery, further reflects this 
relationship as delivery also results in significant reduction 
in IAP. However, due to a lack of clear research in this area, 
these conclusions have yet to be verified.
OVARIAN HYPERSTIMULATION SYNDROME  
AND OTHER GYNECOLOGIC CONDITIONS  
IN RELATION TO IAH
Ovarian hyperstimulation syndrome (OHSS) is an in-
creasingly common complication of ovulation induction 
for assisted reproduction [61, 62]. The mechanism is not 
entirely understood but is a response to exogenous ad-
ministration of human chorionic gonadotropin (HCG) [73]. 
It is hypothesized that the use of HCG in ovulation induc-
tion triggers a systemic inflammatory response resulting 
in increased capillary permeability and ovarian neoangio-
genesis. Significant third space fluid accumulation with 
pleural, pericardial, and abdominal effusions may occur 
as a result of capillary leak (ovarian neoangiogenesis) and 
along with visceral edema, increased IAP may result [61, 62]. 
In its most severe form, massive and rapid accumulation of 
abdominal ascites results in overt ACS [73]. Management 
includes intensive care unit admission with IAP monitor-
ing and paracentesis to relieve IAH or ACS, especially if 
respiratory failure occurs [62, 73]. Figure 3 and Table 1 show 
the evolution of IAP in a patient with OHSS after staged 
paracentesis. During staged evacuation, the compliance of 
the abdominal wall gradually increased from 55 to 191 mL 
cm H2O (Table 1). The compliance can be calculated by the 
change in intra-abdominal volume divided by the change in 
IAP (or thus ΔIAV/ΔIAP). As assisted reproduction increases 
in prevalence, it becomes imperative to recognize this rela-
tively common complication and to consider the potential 
role of IAH in its pathophysiology.
A wide range of additional gynecologic pathology 
can be associated with IAH/ACS related by the propensity 
to cause intra-abdominal mass effects. Meig’s syndrome, 
ovarian mucinous cystadenoma and other solid ovarian tu-
mors for example, are associated with hydrothorax and 
ascites. Definitive therapy usually requires surgical removal 
of the tumor itself [74]. Other reported conditions associated 
with IAH, such as ovarian tumors, are shown in Figure 4 [75].
MANAGEMENT OF IAH DURING PREGNANCY
There remains a significant lack of research and evi-
dence-based recommendations for the management of IAP 
in pregnancy. IAP is elevated in pregnancy and most women 
develop adaptive mechanisms that minimize the impact of 
this pressure [46]. However, IAH may combine with other 
risk factors to either cause or exacerbate several common 
obstetrical/gynecological disease processes. Due to base-
line increases in IAP, all critically ill obstetrical/gynecologic 
patients should undergo vigilant IAP monitoring.
INTRA-ABDOMINAL HYPERTENSION  
IN GENERAL MEDICINE
INTRA-ABDOMINAL PRESSURE MONITORING  
DURING PERITONEAL DIALYSIS
IAP may be markedly increased during acute peritoneal 
dialysis (PD), when a significant amount of dialysis fluid, 
usually 2−4 L in an adult, is introduced into the peritoneal 
cavity. In humans, decreased cardiac output and increased 
pulmonary artery pressures have been reported [76, 77]. 
Figure 5 shows the effects of peritoneal dialysis on con-
tinuous IAP measured via a balloon-tipped catheter in the 
stomach in a mechanically ventilated patient. This increase 
in IAP was associated with an increase in end-tidal CO2 when 
the abdomen was filled. For these reasons, acute PD is not 
Table 1. Evolution of IAP and calculation of abdominal wall compliance in a patient with OHSS (see also Fig. 3)
Day IAP before (mm Hg) IAP After (mm Hg) ΔIAP (mm Hg) Ascites amount (ml) Cab (mL cm H2O–1)
1 30 19 11 600 55
2 27 18 9 1450 161
3 25 14 11 2100 191
Figure 3. Evolution of IAP and CVP in a patient with OHSS. Evolution 
of intra-abdominal pressure (IAP) and central venous pressure (CVP) 
in a patient with ovarian hyperstimulation syndrome (OHSS) after 
gradual staged evacuation of ascites. Note the improvement of 
abdominal wall compliance over time with larger ascites volumes 
needed to result in the same drop in IAP (time markers per 4 hours)
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commonly performed in adults in the intensive care setting, 
but it can be used in circumstances where other forms of 
acute renal replacement therapies are not available [78]. 
Studies comparing acute PD with veno-venous hae-
mofiltration in patients with sepsis-induced acute renal 
failure have reported a significantly higher mortality with 
PD [79]. Although this could be due to less effective dialysis, 
organ dysfunction due to intermittent IAH (up to 2.5 times 
the baseline value) when the abdomen is filled is another 
possible explanation, since this may result in reduced car-
diac output and blood pressure (Fig. 5). A pathophysiologic 
explanation may be compression of the inferior vena cava 
with resultant decreased venous return [76]. Such effects 
could be aggravated in situations of hypovolemia and 
positive pressure ventilation. In children, PD is usually well 
tolerated and it is still a common procedure in critically ill 
pediatric patients who develop acute renal failure.
IAH is a risk factor for abdominal wall complications 
(hernia acquisition and fluid leakage) in patients on chronic 
ambulatory peritoneal dialysis (CAPD) [80]. Besides IAP, ad-
vanced age, polycystic kidney disease, and high BMI were 
also independent risk factors for these complications. Au-
tomated CAPD with low daytime fill volume and pressures 
should be considered in all patients at risk for such com-
plications. A strong correlation between BMI and IAP in 
children on PD has been noted [81], which gives a better 
understanding of the individual variability and of the unique 
relationship between IAP and intraperitoneal volume. It is 
therefore recommended that filling pressures during CAPD 
should be limited to 14 mm Hg [82].
INTRA-ABDOMINAL HYPERTENSION IN THE 
HAEMATOLOGY PATIENT
Recent studies have referred to the increased inci-
dence and consequences of IAH in haematological patients 
[83−85]. The causes are multiple and may also be multi-
factorial. Growth factor-induced capillary leak syndrome 
with concomitant large volume fluid resuscitation and 
third space sequestration, chemotherapy induced ileus, 
colonic pseudo-obstruction (Ogilvie’s syndrome), mucositis 
or gastroenteritis (graft versus host disease) may produce 
IAH. Sepsis and infectious complications aggravating in-
testinal and capillary permeability favor fluid accumula-
tion. Extramedullary hematopoiesis as seen with chronic 
myeloid leukemia can also result in hepatosplenomegaly 
[84], chronic IAH, and chronic (irreversible) pulmonary hy-
pertension. The mechanisms of veno-occlusive disease seen 
after stem cell transplantation may be triggered by or related 
to increased IAP [85].
INTRA-ABDOMINAL HYPERTENSION IN 
GASTROENTEROLOGY
ACS has been described in patients with toxic megaco-
lon related to clostridium difficile gastro-enteritis [86, 87]. 
IAP may also trigger (re)bleeding of esophageal varices in 
patients with end stage liver cirrhosis. These patients often 
require placement of a nasogastric tube to decompress the 
stomach after endoscopy [88]. ACS has been reported after 
colonoscopy complicated with perforated diverticultis or 
during gastroscopy in animals [89, 90]. Ascites as a result of 
liver failure and or hepatorenal syndrome can increase IAP. 
Ascitic fluid can be safely percutaneously drained in patients 
with these conditions [91−93].
Figure 4. Abdominal compartment syndrome in a patient with 
an ovarian mucinous cystadenoma. A 38-year-old woman presenting 
with a tensely distended abdomen developed hypotension, 
respiratory distress, and oliguria based on the diagnosis of 
an ovarian tumor complicated by abdominal compartment 
syndrome. Contrast enhanced CT of the abdomen shows 
an inhomogeneous mass of 20 by 15 cm, expanding to all directions 
(arrows) and compressing the surrounding vascular structures
Figure 5. Effect of peritoneal dialysis on IAP measured continuously 
via the stomach. Continuous IAP tracing in a patient on peritoneal 
dialysis. The IAP was measured via a balloon-tipped nasogastric 
tube connected to a Spiegelberg monitor (Spiegelberg, Hamburg, 
Germany). Dialysis fluid was instilled into the abdominal cavity at 
9:00; 13:00 and 21:00 (large arrows). When the abdomen was filled, 
the IAP increased from baseline values of 9 mm Hg up to 22 mm Hg 
and this resulted in difficult ventilation with a drop in tidal volume 
and increased end tidal CO2 values. The dotted line shows the IAH 
grade I threshold of 12 mm Hg
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INTRA-ABDOMINAL HYPERTENSION  
IN RESPIRATORY CONDITIONS
ACS has been associated with noninvasive ventilation 
with the head of bed (HOB) at 45° due to aerophagia [94], 
in relation to tension pneumothorax [95, 96], and IAH has 
been reported in COPD patients when measured at end-ex-
piration during forced breathing [97]. ACS and acute kidney 
injury due to excessive auto-positive end-expiratory pres-
sure have also more recently been described in a patient 
with severe COPD [98].
INTRA-ABDOMINAL HYPERTENSION  
IN NEUROLOGIC CONDITIONS
Raised IAP due to constipation, ileus, or small bowel ob-
struction has been reported to play a role in malfunctioning 
ventriculo-peritoneal shunts in patients with hydrocephalus 
[99]. Within the concept of the polycompartment syndrome 
increased IAP may be an extracranial cause for increased 
intracranial pressure (ICP) in patients with combined cra-
nial and abdominal trauma [100]. Scalea et al. was the first 
to introduce the term multiple compartment syndrome 
in a study of 102 patients with increased intra-abdominal 
(IAP), intrathoracic (ITP), and intracranial (ICP) pressures after 
severe brain injury [100]. These authors suggested that dif-
ferent compartments within the body are not isolated and 
independent entities but instead are closely connected. 
As the term multi- or multiple compartment syndrome is 
now mostly used in relation to multiple limb trauma need-
ing fasciotomy, the term polycompartment syndrome (PCS) 
was proposed in order to avoid confusion [101] and is now 
accepted [44]. While a discussion of the PCS is beyond the 
scope of this paper, it is important for the clinician to un-
derstand that pressure-related interactions occur between 
the four major bodily compartments: the brain, thorax, ab-
domen, and extremities [102, 103]. Laparoscopic surgery 
is therefore not the first option in patients with traumatic 
brain injury and increased ICP [104]. 
INTRA-ABDOMINAL HYPERTENSION  
IN RENAL CONDITIONS
IAH is now recognized as a risk factor for the develop-
ment of acute kidney injury and failure in the renal literature 
[10, 105, 106]. Although the effects of increased IAP are 
multiple, the kidney is especially vulnerable to increased 
IAP because of its anatomic position. While the means by 
which kidney function is impaired in patients with ACS 
is incompletely elucidated, available evidence suggests 
that the most important factor involves alterations in renal 
blood flow. IAH should be considered as a potential cause 
of acute kidney injury in critically ill patients; its role in other 
conditions, such as hepatorenal syndrome, remains to be 
elucidated. Because several treatment options (both medical 
and surgical) are available, IAH and ACS should no longer 
be considered irrelevant epiphenomena of severe illness 
or critical care [107].
INTRA-ABDOMINAL HYPERTENSION  
IN CARDIAC CONDITIONS
Increased IAP has been related to coronary artery bypass 
surgery and prolonged extracorporeal circuit times [108, 
109]. In chronic heart failure and cardiorenal dilemma or 
cardiorenal syndrome, IAH is associated with deteriorating 
renal function [110, 111]. Devices to induce hypothermia 
after cardiac arrest use a closed loop system with the instil-
lation of cold fluids into the peritoneal cavity. For safety 
reasons, these devices limit the instillation of fluids based 
on IAP, with target pressures below 15 mm Hg.
The abdominal compartment could potentially form 
a missing link in the pathophysiology of acute decompen-
sated heart failure (ADHF) and cardio-renal syndrome. It has 
recently been shown that raised IAP is prevalent in advanced 
heart failure causing reduced ejection fraction and the impair-
ment of renal function [110]. However, IAH and ACS are less 
frequent and overt ascites is rare [110]. Importantly, medi-
cal treatment resulting in a decrease of IAP improves renal 
function and in cases of persistently high IAP, ultrafiltration 
might be beneficial [110, 111]. Notably, while organ dysfunc-
tion in the intensive care literature has only been described 
when IAP exceeds 12 mm Hg, patients with ADHF develop 
worsening renal function at much lower IAP levels [110]. This 
might suggest that the underlying reserve of the kidneys is 
impaired with increased IAP in this setting. It is also vital to 
emphasize that although the degree of renal dysfunction is 
probably correlated with the degree of IAP elevation, there 
can be a wide range of IAP in relation to serum creatinine 
levels at presentation [110]. Therefore, the term Cardio-Ab-
domino-Renal Syndrome or CARS, helps to emphasize the 
potentially important role of the abdominal compartment 
and splanchnic vasculature in the pathophysiology of ADHF 
and cardio-renal syndrome [112].
SUMMARY KEY POINTS 
IAH IN BURN PATIENTS
•	 IAH will develop in most if not all severely burned pa-
tients, and may become rapidly fatal.
•	 The incidence of IAH is directly related to the burned 
surface (TBSA > 60%) and the amount of fluids given 
(> 275 mL kg-1 first 24 hours).
•	 Always suspect IAH and routinely measure the IAP in 
the resuscitation period.
•	 Avoid over-resuscitation with large volumes and overuse 
of crystalloids.
•	 Consider the use of hypertonic solutions to minimize 
fluid accumulation.
10
Anaesthesiol Intensive Ther [ahead of print]
•	 Percutaneous drainage of ascites is a simple and ef-
fective tool to reduce IAP if organ dysfunction devel-
ops. Consider diuretics and CVVH with net ultrafiltration.
•	 Escharotomy can dramatically reduce IAP in case of 
circular abdominal (but also thoracic) burns and will 
improve abdominal wall compliance
•	 Although decompressive laparotomy is a definitive 
therapy, wound maintenance and infection control may 
then become difficult.
•	 Knowing the risk of ACS is important.
IAH AND OBESITY 
•	 Although acute elevations in IAP have similar effects in obese 
patients compared to non-obese patients, the threshold 
before organ dysfunction develops may be higher.
•	 Chronic elevations in IAP may, in part, be responsible for 
the pathogenesis of obesity-related co-morbid condi-
tions such as hypertension, pseudotumor cerebri, pul-
monary dysfunction, GERD, and abdominal wall hernias. 
•	 Further large-scale studies are necessary to determine 
the relationship between chronic IAP and obesity-relat-
ed co-morbidities.
IAH AND PREGNANCY
•	 The IAP is chronically increased during pregnancy
•	 Because the body has time to adapt end-organ dysfunc-
tion is rare
•	 The IAP should not be measured in the supine position 
but in the left lateral decubitus at 10°
•	 Laparoscopy can have deleterious effects on the fetus 
and should be performed with caution and only when 
absolutely indicated in the third trimester.
•	 IAH is associated with preeclampsia and eclampsia.
•	 Paracentesis is treatment of choice for ovarian hyper-
stimulation syndrome (OHSS).
IAH IN GENERAL MEDICINE
•	 IAP has been increasingly recognized to play a major 
role in different pathologies and is emerging in every 
field of medicine in the last decades.
•	 Fill volume during peritoneal dialysis should be limited 
to an IAP of 14 mm Hg.
•	 Cardiorenal syndrome should be termed CARS, car-
dio-abdomino-renal syndrome instead.
•	 An IAP > 9 mm Hg may play a role in the deterioration of 
renal function in patients with congestive heart failure.
•	 Think of the organ-organ interactions and PCS, poly-
compartment syndrome.
CONCLUSIONS
The occurrence of IAH and ACS has been associated 
in many conditions beyond the classical ICU, surgical or 
trauma patient. The true incidence of IAH in burns, obe-
sity, pregnancy and general medicine is high and probably 
underestimated. In adults but also in children, patients at 
risk for IAH should be identified early during the treatment 
and the focus should be on early recognition of IAH and 
prevention of ACS. Thus, IAP should be measured regularly. 
Appropriate actions should be taken when IAP increases 
above 15 mm Hg, especially in patients difficult to venti-
late or those with new onset organ dysfunction. Although 
medical management comes first, one should not hesitate 
to resort to surgical decompression if this fails. 
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